315 related articles for article (PubMed ID: 10559313)
21. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
Wu X; Liu H; Xiao H; Conway JA; Kappes JC
J Virol; 1996 Jun; 70(6):3378-84. PubMed ID: 8648668
[TBL] [Abstract][Full Text] [Related]
22. Targeting a foreign protein into virion particles by fusion with the Vpx protein of simian immunodeficiency virus.
Park IW; Sodroski J
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):341-50. PubMed ID: 8601220
[TBL] [Abstract][Full Text] [Related]
23. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.
Paxton W; Connor RI; Landau NR
J Virol; 1993 Dec; 67(12):7229-37. PubMed ID: 8230445
[TBL] [Abstract][Full Text] [Related]
24. Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag).
Accola MA; Ohagen A; Göttlinger HG
J Virol; 2000 Jul; 74(13):6198-202. PubMed ID: 10846106
[TBL] [Abstract][Full Text] [Related]
25. Degradation of SAMHD1 by Vpx Is Independent of Uncoating.
Jáuregui P; Logue EC; Schultz ML; Fung S; Landau NR
J Virol; 2015 May; 89(10):5701-13. PubMed ID: 25762741
[TBL] [Abstract][Full Text] [Related]
26. Amino acid sequence requirements for the incorporation of the Vpx protein of simian immunodeficiency virus into virion particles.
Park IW; Sodroski J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):506-10. PubMed ID: 8548329
[TBL] [Abstract][Full Text] [Related]
27. Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag).
Jenkins Y; Pornillos O; Rich RL; Myszka DG; Sundquist WI; Malim MH
J Virol; 2001 Nov; 75(21):10537-42. PubMed ID: 11581428
[TBL] [Abstract][Full Text] [Related]
28. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
Huang M; Orenstein JM; Martin MA; Freed EO
J Virol; 1995 Nov; 69(11):6810-8. PubMed ID: 7474093
[TBL] [Abstract][Full Text] [Related]
29. Differential association of uracil DNA glycosylase with SIVSM Vpr and Vpx proteins.
Sleigh R; Sharkey M; Newman MA; Hahn B; Stevenson M
Virology; 1998 Jun; 245(2):338-43. PubMed ID: 9636373
[TBL] [Abstract][Full Text] [Related]
30. Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex.
Yurkovetskiy L; Guney MH; Kim K; Goh SL; McCauley S; Dauphin A; Diehl WE; Luban J
Nat Microbiol; 2018 Dec; 3(12):1354-1361. PubMed ID: 30297740
[TBL] [Abstract][Full Text] [Related]
31. The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr.
de Rocquigny H; Petitjean P; Tanchou V; Decimo D; Drouot L; Delaunay T; Darlix JL; Roques BP
J Biol Chem; 1997 Dec; 272(49):30753-9. PubMed ID: 9388214
[TBL] [Abstract][Full Text] [Related]
32. Nuclear export of simian immunodeficiency virus Vpx protein.
Singhal PK; Rajendra Kumar P; Subba Rao MR; Mahalingam S
J Virol; 2006 Dec; 80(24):12271-82. PubMed ID: 16987982
[TBL] [Abstract][Full Text] [Related]
33. Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx.
Cassiday PA; DePaula-Silva AB; Chumley J; Ward J; Barker E; Planelles V
Virology; 2015 Feb; 476():19-25. PubMed ID: 25499532
[TBL] [Abstract][Full Text] [Related]
34. Comparative study on the structure and cytopathogenic activity of HIV Vpr/Vpx proteins.
Khamsri B; Murao F; Yoshida A; Sakurai A; Uchiyama T; Shirai H; Matsuo Y; Fujita M; Adachi A
Microbes Infect; 2006 Jan; 8(1):10-5. PubMed ID: 16153874
[TBL] [Abstract][Full Text] [Related]
35. Evolutionary toggling of Vpx/Vpr specificity results in divergent recognition of the restriction factor SAMHD1.
Fregoso OI; Ahn J; Wang C; Mehrens J; Skowronski J; Emerman M
PLoS Pathog; 2013; 9(7):e1003496. PubMed ID: 23874202
[TBL] [Abstract][Full Text] [Related]
36. Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1.
Kino T; Pavlakis GN
DNA Cell Biol; 2004 Apr; 23(4):193-205. PubMed ID: 15142377
[TBL] [Abstract][Full Text] [Related]
37. The Vpr protein from HIV-1: distinct roles along the viral life cycle.
Le Rouzic E; Benichou S
Retrovirology; 2005 Feb; 2():11. PubMed ID: 15725353
[TBL] [Abstract][Full Text] [Related]
38. Identification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virion.
Zhu H; Jian H; Zhao LJ
Retrovirology; 2004 Sep; 1():26. PubMed ID: 15363109
[TBL] [Abstract][Full Text] [Related]
39. Vpr-induced cell cycle arrest is conserved among primate lentiviruses.
Planelles V; Jowett JB; Li QX; Xie Y; Hahn B; Chen IS
J Virol; 1996 Apr; 70(4):2516-24. PubMed ID: 8642681
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 particle release mediated by Vpu is distinct from that mediated by p6.
Schwartz MD; Geraghty RJ; Panganiban AT
Virology; 1996 Oct; 224(1):302-9. PubMed ID: 8862425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
